RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAIÂ’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.
| CEO: |
James Renwick McCullough |
| Non-Executive Director: |
Daniel J. Levangie, Catherine Coste, Erik Kristian Lium |
| Non-Executive Chairman: |
Christopher H B Mills |
| Chief Technical Officer: |
Fergus Fleming |
| Address: |
2 Leman Street, London, United Kingdom |
| Phone: |
|
| Fax: |
|
| Website: |
http://www.renalytix.com/ |
| Email: |
|